Clinical Research

Axela’s dotLab® System is specifically targeted to overcoming the challenges of the protein biomarker development process.

Clinical researchers interested in significantly improving the efficiency of post discovery biomarker assay development and validation will appreciate the dotLab’s combination of: 

  • Real-time interaction detection
  • Flow based assay formats
  • Multiplexing designed for use directly with complex samples

The dotLab System offers speed to result, sensitivity and reduced sample consumption. The integrated system is easy to use yet flexible enough to be applied to a wide range of studies.

The dotLab System provides:

  • Rapid understanding of molecular interactions
  • Flexible assay formats
  • High sensitivity
  • Broad dynamic range
  • Minimal sample requirements
  • Direct protein quantitation
  • Simplified data analysis
  • Multiplexing

Key dotLab applications of interest to Clinical Researchers:

  • Biomarker Validation: Rapidly develop assays to quantitate novel biomarkers while conserving precious sample
  • Assay Development: Real-time optimization eliminates tedious checkerboard approaches
  • Analyte Quantitation: Robust measurement of micromolar concentrations
  • Isoforms & Complexes: Sequential probing to directly characterize modifications or interactions
  • Immunogenicity Testing: Quantitation and isotype in the same assay
  • Multiplex: Multiple analyte detection and forward compatible with addressable sensors